1. Home
  2. OCFC vs HROW Comparison

OCFC vs HROW Comparison

Compare OCFC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OceanFirst Financial Corp.

OCFC

OceanFirst Financial Corp.

HOLD

Current Price

$18.90

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

HROW

Harrow Inc.

N/A

Current Price

$37.11

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OCFC
HROW
Founded
1902
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
OCFC
HROW
Price
$18.90
$37.11
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$21.67
$69.86
AVG Volume (30 Days)
967.2K
540.7K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
4.24%
N/A
EPS Growth
N/A
71.43
EPS
0.27
N/A
Revenue
N/A
N/A
Revenue This Year
$47.51
$31.62
Revenue Next Year
$21.97
$50.77
P/E Ratio
$69.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.05
$28.54
52 Week High
$20.61
$54.98

Technical Indicators

Market Signals
Indicator
OCFC
HROW
Relative Strength Index (RSI) 43.21 39.04
Support Level $17.31 $32.74
Resistance Level $19.35 $42.40
Average True Range (ATR) 0.31 1.93
MACD -0.06 -0.30
Stochastic Oscillator 20.18 13.16

Price Performance

Historical Comparison
OCFC
HROW

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: